Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer

Overview of attention for article published in Frontiers in oncology, September 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 6 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 27,455 followers.

RT @FrontOncology: New research: Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer: As the predominant treatment option o…

05 Sep 2022

Reply Repost Favourite

Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer: As the predominant treatment option of the immunotherapy for advanced esophageal cancer (EC), the application of programmed death 1 (PD-1) and programmed… #oncology https://t.co/Forre2iRs

05 Sep 2022

Reply Repost Favourite

New research: Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer: As the predominant treatment option of the immunotherapy for advanced esophageal cancer (EC), the application of programmed death 1 (PD-1) and programmed… https://t.co/L7crF

05 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.